FDA Releases Final Guidance on Civil Money Penalties for ClinicalTrials.gov Data Bank Violations

Summary

The US Food and Drug Administration (FDA) has released a final guidance document outlining the agency's approach to assessing civil money penalties for non-compliance with clinical trial registration and reporting requirements to the ClinicalTrials.gov data bank.